Posted inSector Analysis
HIV Diagnosis in Europe: Uncovering a Public Health Crisis and Biotech Investment Opportunities
Over 50% of HIV diagnoses in Europe are made too late for optimal treatment, revealing a silent public health crisis. This trend presents both challenges for healthcare systems and emerging biotech investment opportunities in diagnostics, antiretrovirals, and prevention technologies.
